pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Approval · news · pharmadog
← back to Approval
News · Approval
1,551
stories
Sep 23, 26
Roche’s phase 3 win tees up fight with Novartis for blockbuster kidney disease market
fiercebiotech
Sep 22, 26
Amgen reports a Phase 3 win with Sjögren’s drug candidate
biopharma dive
Sep 22, 26
Opinion: Former FDA commissioners: Heidi Overton has an opportunity to strengthen the FDA
stat
Sep 22, 26
Compass vows to press on with FDA application despite new trial request
biospace
Sep 22, 26
Celldex sinks as safety concerns cloud immune drug results
biopharma dive
Sep 22, 26
Vertex opens up larger kidney disease opportunity with mid-stage readout
biospace
Sep 22, 26
STAT+: Novo may be getting a better deal than expected with Medicare’s Bridge program
stat
Sep 22, 26
2026 IPO blitz continues with 4 new biotech filings
biospace
Sep 22, 26
Novartis secures new radioligand in $900M deal as competition strengthens
fiercebiotech
Sep 22, 26
STAT+: Pharmalittle: We’re reading about pharma seeking to protect China deals, a Roche obesity drug, and more
stat
Sep 22, 26
Celldex monoclonal antibody rebounds with pair of phase 3 wins for chronic skin condition
fiercebiotech
Sep 22, 26
Amgen’s Horizon-acquired fusion protein eases Sjögren's severity in ph. 3 win
fiercebiotech
Sep 22, 26
Vertex’s midstage data amplify kidney disease market opportunity
fiercebiotech
Sep 22, 26
Siemens Healthineers and Novo team up on fatty liver disease awareness, testing
fiercebiotech
Sep 22, 26
STAT+: Ohio governor’s race is a battle over Covid, health costs, and trust in science
stat
Sep 22, 26
Cordis’ sirolimus drug-coated balloon earns FDA approval as a breakthrough device
fiercebiotech
Sep 21, 26
Beacon eye gene therapy hits mark in late-stage study
biopharma dive
Sep 21, 26
STAT+: What a vote on Grail’s cancer detection test could mean for the company, patients, and regulators
stat
Sep 21, 26
Novo talks up drug launches in effort to win back investors
biopharma dive
Sep 21, 26
FDA approves ataxia-telangiectasia drug; Alkermes reports ADHD data
endpoints
Sep 21, 26
Novo offers low-dose CagriSema data as approval decision looms
endpoints
Sep 21, 26
STAT+: Lilly’s breast cancer combo wins approval
stat
Sep 21, 26
Novo’s plan to hit $23B in revenue by 2035 leaves investors wanting
biospace
Sep 21, 26
Telix buys ITM in bid to create a ‘radiopharmaceutical powerhouse’
biopharma dive
Sep 21, 26
How J&J paved the way for Compass’ coming psychedelic drug launch
biopharma dive
Sep 21, 26
Novo struggles to appease restive investors with consumer plans, blockbuster ambitions
fiercebiotech
Sep 21, 26
Opinion: STAT+: The NIH budget should be $100 billion per year
stat
Sep 21, 26
Analysts ‘extremely bullish’ as Telix beams into Novartis’ territory with $1.6B ITM acquisition
fiercebiotech
Sep 21, 26
Citing Replimune approval, experts say localized cancer meds could redefine care
biospace
Sep 21, 26
Mikhail, Davis on board with regulatory framework tailored to rare disease therapies
biospace
← prev
page 19 of 52
next →